Stocktoria

AtaiBeckley Inc. ATAI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-18 · LEI

AtaiBeckley Inc. statistics & valuation

Market cap$1.9B
P / B8.8×
Net margin-16142.0%
FCF margin-2533.0%
Net cash$85.3M
Enterprise value USD$1.9B
Earnings yield EBIT/EV-34.6%
Return on capital-239.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-48464.00% -16142.00% 20242025
Gross margin (%)
20242025
Operating margin (%)
-33341.20% -15751.10% 20242025
Return on equity (%)
-128.10% -297.30% 20242025
Shares outstanding
168.0M 363.3M 20242025
Net debt ($)
-$3.4M -$85.3M 20242025
Share buybacks ($)
20242025
Return on assets (%)
-93.70% -225.50% 20242025
Free cash flow margin (%)
-26767.20% -2533.00% 20242025
Debt / equity (×)
0.12× 0.00× 20242025
EPS ($)
-$0.93 -$2.91 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Operating margin-15751.1%-33341.2%
Net margin-16142.0%-48464.0%
FCF margin-2533.0%-26767.2%
Return on assets-225.5%-93.7%
Return on equity-297.3%-128.1%
Debt / equity0.00×0.12×
Current ratio11.743.21

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.